Achieve Life Sciences Files Prospectus Related To Offer & Sale From Time To Time Of Up To 13.1M Shares Of Common Stock, By Selling Stockholders

Achieve Life Sciences Files Prospectus Related To Offer & Sale From Time To Time Of Up To 13.1M Shares Of Common Stock, By Selling Stockholders

BenzingaApr 27 04:39

Jones Starts Achieve Life Sciences at Buy, Cites Market Opportunity

Seeking AlphaApr 18 05:41

Achieve Life Sciences (ACHV.US) was first covered by JonesTrading, giving it a buy rating, with a target price of $20.00.

Achieve Life Sciences (ACHV.US) was first covered by JonesTrading, giving it a buy rating, with a target price of $20.00.

Zhitong FinanceApr 17 22:20

JonesTrading Initiates Coverage On Achieve Life Sciences With Buy Rating, Announces Price Target of $20

JonesTrading analyst Justin Walsh initiates coverage on Achieve Life Sciences (NASDAQ:ACHV) with a Buy rating and announces Price Target of $20.

BenzingaApr 17 22:14

Achieve Life Sciences: A Strong Buy for Tobacco Cessation Market Penetration

TipRanksApr 17 04:25

Achieve Life Sciences to Present at Life Science Innovation Northwest 2024 Conference

Achieve Life Sciences, Inc. (Nasdaq: ACHV) today announced that John Bencich, CEO of Achieve, will present at the Life Science Innovation Northwest (LSINW) 2024 Conference being held at the Seattle Convention Center April 17-18, 2024.

GlobeNewswireApr 11 20:00